In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other factors play a significant role in repeating outbreaks.
|Videos|March 27, 2018
What Can Physicians Do If Their Patient Declines Getting Tested for HIV?
Author(s)Contagion® Editorial Staff
Colleen Kelley, MD, stresses the importance of routinizing HIV testing and shares what physicians can do if their patient declines the option to get tested.
Advertisement
Colleen Kelley, MD, associate professor of medicine for the Division of Infectious Diseases in the department of Medicine at Emory University School of Medicine, stresses the importance of routinizing HIV testing; by making it part of routine health care, it makes the suggestion of a test not so much of an anomaly for patients. Dr. Kelley also shares what physicians can do if their patient declines the option to get tested for the virus.
Advertisement
Related to this article
In the second episode of the series with Perry N. Halkitis, PhD, MS, MPH, he brings his personal experience to this topic and questions whether there should be a shift in who manages the primary care needs of these patients.
Here is a review of glucagon-like peptide-1 receptor agonist use in people with HIV.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
New gyrA testing guides ciprofloxacin use for gonorrhea, cutting ceftriaxone reliance while tackling resistance, access, and FDA hurdles.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
Advertisement
Advertisement
Trending on Contagion Live
1
US Company Recalls Thousands of Pounds of Uninspected Meat
2
Carbapenem-Sparing Therapy for ESBL Bacteremia: New Trials, Old Questions
3
How The Food Safety Surveillance Infrastructure Works in the US
4
Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
5